References
- BourgaultCSenecalMBrissonMPersistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based studyJ Hum Hypertens2005196071315920457
- Breekveldt-PostmaNSHeringsRMPersistence with antihypertensives related to formulation: the case of nifedipineAnn Pharmacother2005392374215598968
- CaroJJSalasMSpeckmanJLPersistence with treatment for hypertension in actual practiceCMAJ1999a1603179934341
- CaroJJSpeckmanJLSalasMEffect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice dataCMAJ1999b1604169934342
- CatalanVLelorierJPredictors of long-term persistence on statins in a subsidized clinical populationValue in Health200034172516464201
- ChouCCLeeMSKeCHFactors influencing the switch in the use of antihypertensive medicationsInt J Clin Pract200559859115707471
- DeziiCMPersistence with drug therapy: a practical approach using administrative claims dataManag Care20011042511236643
- DicpinigaitisPVAngiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelinesChest2006129169S73S16428706
- ErkensJAPannemanMMKlungelOHDifferences in antihypertensive drug persistence associated with drug class and gender: a PHARMO studyPharmacoepidemiol Drug Saf20051479580316178043
- ESHEuropean Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertensionJ Hypertens20032110115312777938
- GerthWCCompliance and persistence with newer antihypertensive agentsCurr Hypertens Rep200244243312419170
- GueyffierFBoutitieFBoisselJPEffect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA InvestigatorsAnn Intern Med199712676179148648
- HalpernMTKhanZMSchmierJKRecommendations for evaluating compliance and persistence with hypertension therapy using retrospective dataHypertension20064710394816651464
- HasfordJMimranASimonsWRA population-based European cohort study of persistence in newly diagnosed hypertensive patientsJ Hum Hypertens2002165697512149663
- HeringsRThesis. PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in The Netherlands1993UtrechtUtrecht University
- KoylanNAcarturkECanberkAEffect of irbesartan monotherapy compared with ACE inhibitors and calcium-channel blockers on patient compliance in essential hypertension patients: a multicenter, open-labeled, three-armed studyBlood Press Suppl20051233116060413
- ManciaGSeravalleGGrassiGTolerability and treatment compliance with angiotensin II receptor antagonistsAm J Hypertens20031610667314643584
- MarentetteMAGerthWCBillingsDKAntihypertensive persistence and drug classCan J Cardiol2002186495612107422
- MazzagliaGMantovaniLGSturkenboomMCPatterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary careJ Hypertens200523209310016208153
- MorganSGYanLPersistence with hypertension treatment among community-dwelling BC seniorsCan J Clin Pharmacol200411e2677315596883
- PerreaultSLamarreDBlaisLPersistence with treatment in newly treated middle-aged patients with essential hypertensionAnn Pharmacother2005391401816076920
- RossSWalkerAMacleodMJPatient compliance in hypertension: role of illness perceptions and treatment beliefsJ Hum Hypertens2004186071315029218
- SteinerJFProchazkaAVThe assessment of refill compliance using pharmacy records: methods, validity, and applicationsJ Clin Epidemiol199750105169048695
- SvenssonSKjellgrenKIAhlnerJReasons for adherence with antihypertensive medicationInt J Cardiol2000761576311104870
- WHOAdherence to long-term therapies: evidence for action2003GenevaWorld Health Organization
- WogenJKreilickCALivorneseRCPatient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care settingJ Manag Care Pharm20039424914613440